Acute Cholesterol-Lowering Effect of Exendin-4 in <i>Ldlr</i><sup>−/−</sup> and C57BL/6J Mice-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Acute Cholesterol-Lowering Effect of Exendin-4 in <i>Ldlr</i><sup>−/−</sup> and C57BL/6J Mice

Published:2023-01-01 Issue:1 Volume:30 Page:74-86
ISSN:1340-3478
Container-title:Journal of Atherosclerosis and Thrombosis
language:en
Short-container-title:JAT

Author:

Hori Mika¹,Hasegawa Yukiko²,Hayashi Yoshitaka³,Nakagami Tomoko²,Harada-Shiba Mariko¹

Affiliation:

1. Department of Molecular Innovation in Lipidology, National Cerebral and Cardiovascular Center Research Institute

2. Division of Diabetology and Metabolism, Department of Internal Medicine, Tokyo Women’s Medical University School of Medicine

3. Department of Endocrinology, Research Institute of Environmental Medicine, Nagoya University

Publisher

Japan Atherosclerosis Society

Subject

Biochemistry (medical),Cardiology and Cardiovascular Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/jat/30/1/30_60921/_pdf

Reference28 articles.

1. 1) MacDonald PE, El-Kholy W, Riedel MJ, Salapatek AM, Light PE and Wheeler MB: The multiple actions of GLP-1 on the process of glucose-stimulated insulin secretion. Diabetes, 2002; 51 Suppl 3: S434-442

2. 2) Yamato E, Noma Y, Tahara Y, Ikegami H, Yamamoto Y, Cha T, Yoneda H, Ogihara T, Ohboshi C, Hirota M and Shima K: Suppression of synthesis and release of glucagon by glucagon-like peptide-1 (7-36 amide) without affect on mRNA level in isolated rat islets. Biochem Biophys Res Commun, 1990; 167: 431-437

3. 3) Viswanathan P, Chaudhuri A, Bhatia R, Al-Atrash F, Mohanty P and Dandona P: Exenatide therapy in obese patients with type 2 diabetes mellitus treated with insulin. Endocr Pract, 2007; 13: 444-450

4. 4) Klonoff DC, Buse JB, Nielsen LL, Guan X, Bowlus CL, Holcombe JH, Wintle ME and Maggs DG: Exenatide effects on diabetes, obesity, cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes treated for at least 3 years. Curr Med Res Opin, 2008; 24: 275-286

5. 5) Horton ES, Silberman C, Davis KL and Berria R: Weight loss, glycemic control, and changes in cardiovascular biomarkers in patients with type 2 diabetes receiving incretin therapies or insulin in a large cohort database. Diabetes Care, 2010; 33: 1759-1765

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Glucagon-Like Peptide-1: New Regulator in Lipid Metabolism;Diabetes & Metabolism Journal;2024-05-31

2. Cow’s Milk Allergy May Induce Lipid Metabolism Disorder in BALB/c Mice via Exosomes;Journal of Agricultural and Food Chemistry;2024-01-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3